Effect of random seed placement error in permanent transperineal prostate seed implant

被引:21
作者
Bues, Martin
Holupka, Edward J.
Meskell, Paul
Kaplan, Irving D.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[2] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA
关键词
prostate cancer; seed implant; random seed placement error;
D O I
10.1016/j.radonc.2006.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Random seed placement error may adversely effect dose distribution in transperineal prostate seed implants. In this study, we investigated the extent to which individual seed activity influences dose-distribution degradation due to random seed placement error. Patients and methods: Separate initial treatment plans were prepared for three prostate sizes, 27.3, 43.2 and 48.9 cc, using 0.35, 0.55 and 0.75 mCi iodine-125 seeds. All stated activities are understood to be apparent activities. The combinations produced a total of nine treatment plans. Each initial treatment plan was subjected to 1000 stochastic three-dimensional Gaussian perturbations of seed location, with a standard deviation of 4 mm for a total of 9000 treatment plans. The resulting plans were evaluated for target coverage and urethra involvement. Results: Satisfactory initial treatment plans were prepared for all prostate sizes and seed activities. All 9000 perturbed treatment plans showed acceptable target coverage under the D90/90 criterion. Some of the perturbed plans for the 27.3 and 43.2 cc prostates with 0.55 and 0.75 mCi seeds failed the V100/90 criterion. Some of the randomly perturbed seed distributions showed significantly increased doses to the urethra relative to the unperturbed treatment plan. This effect was more pronounced with greater seed activity. Conclusions: There may be a higher probability of unfavorable target coverage due to random seed placement error when performing transperineal iodine-1 25 prostate seed implants using seeds with activity greater than 0.35 mCi. There may also be a higher probability of unfavorable urethra involvement when using higher activity seeds. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 18 条
[1]   Pre- and post-implant dosimetry: an inter-comparison between UK prostate brachytherapy centres [J].
Al-Qaisieh, B .
RADIOTHERAPY AND ONCOLOGY, 2003, 66 (02) :181-183
[2]  
[Anonymous], 1987, ENDOCURIETHER HYPERT
[3]   Results of permanent prostate brachytherapy, 13 years of experience at a single institution [J].
Battermann, JJ ;
Boon, TA ;
Moerland, MA .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (01) :23-28
[4]   The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs [J].
Beaulieu, L ;
Archambault, L ;
Aubin, S ;
Oral, E ;
Taschereau, R ;
Pouliot, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04) :1298-1308
[5]   DOSE EFFECTS OF SEEDS PLACEMENT DEVIATIONS FROM PRE-PLANNED POSITIONS IN ULTRASOUND-GUIDED PROSTATE IMPLANTS [J].
DAWSON, JE ;
WU, T ;
ROY, T ;
GU, JY ;
KIM, H .
RADIOTHERAPY AND ONCOLOGY, 1994, 32 (03) :268-270
[6]   Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method [J].
Kang, SK ;
Chou, RH ;
Dodge, RK ;
Clough, RW ;
Kang, HSL ;
Bowen, MG ;
Steffey, BA ;
Das, SK ;
Zhou, SM ;
Whitehurst, AW ;
Buckley, NJ ;
Kim, JH ;
Joyner, RE ;
Sarmina, I ;
Montana, GS ;
Ingram, SS ;
Anscher, MS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :937-945
[7]   Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes [J].
Mangili, P ;
Stea, L ;
Cattani, F ;
Lappi, S ;
Giglioli, F ;
Calamia, E ;
Ziglio, F ;
Martinelli, R ;
Longobardi, B .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (01) :13-21
[8]   Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators [J].
Matzkin, H ;
Kaver, I ;
Bramante-Schreiber, L ;
Agai, R ;
Merimsky, O ;
Inbar, M .
RADIOTHERAPY AND ONCOLOGY, 2003, 68 (03) :289-294
[9]   Factors predicting for urinary incontinence after prostate brachytherapy [J].
McElveen, TL ;
Waterman, FM ;
Kim, H ;
Dicker, AP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05) :1395-1404
[10]   DOSIMETRY OF INTERSTITIAL BRACHYTHERAPY SOURCES - RECOMMENDATIONS OF THE AAPM RADIATION-THERAPY COMMITTEE TASK GROUP NO 43 [J].
NATH, R ;
ANDERSON, LL ;
LUXTON, G ;
WEAVER, KA ;
WILLIAMSON, JF ;
MEIGOONI, AS .
MEDICAL PHYSICS, 1995, 22 (02) :209-234